PRA International Expands Scandinavian Operations

New Office Opening in Sweden

News provided by

Jun 15, 2011, 09:00 ET

RALEIGH, N.C., June 15, 2011 /PRNewswire/ -- PRA, a leading Clinical Research Organization, announces the recent opening of a new office in Lund, Sweden to support continued growth in the area. The facility enhances local staff members' ability to provide quality clinical services across Scandinavia.

The Swedish office is located in the thriving region of Oresund, a hub for life science businesses. Oresund is centrally situated in the Medicon Valley, widely known as one of Europe's primary centers for biotech and pharmaceutical activity. The region is also home to several top universities, providing access to leading academic research.

PRA began operating in Sweden in 2005 and demand for services in the region has steadily increased. Over just the past three years, PRA's Swedish staff has increased over 350%. The new office provides a base of operations for area staff, including clinical research associates, team leaders, country start-up specialists, and other roles needed to conduct full-service Phase II - IV clinical trials. PRA's team in Scandinavia includes, in addition to our Swedish employees, staff in Denmark, Finland and Norway.

"PRA's new office in Sweden is an exciting development that showcases our commitment to expansion in Europe and beyond," said Dr. Ludger Langer, PRA's Vice President of Clinical Operations in Europe, Asia-Pacific and Africa. "Providing our local teams with a centralized location for operations strengthens our client offerings in this region."

With over 40 offices worldwide, PRA continues to grow and expand into various regions for clinical research. The new Lund facility further demonstrates our commitment to meeting fluctuating needs of our clients in an ever-changing clinical trials environment.

About PRA

PRA is transforming clinical trials through our people, innovation and transparency. PRA provides personalized service customized to the unique requirements of each study. We support our global reach and innovative approach through flexible and reliable service, delivered by skilled employees dedicated to ensuring that sponsors achieve their long-term goals.

We serve our clients across all phases of pharmaceutical and biotech drug development by combining therapeutic and operational expertise with local knowledge. Offering services in 80+ countries and serving sponsors for 30+ years, we have amassed a level of expertise that has enabled us to work on a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs. But at PRA, we are looking to the future, not the past. Our increasingly forward-thinking approach to transforming the clinical trial landscape will continue to make a difference to healthcare patients around the world.

To learn more about PRA please visit prainternational.com, email [email protected] or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA